Renal Impairment: Enpatoran Study
We are investigating how kidney function impacts the way the drug Enpatoran is absorbed and used in the body. This study aims to improve treatment for patients with renal impairment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
CRS Clinical Research Services Management GmbH
Clinical Pharmacology Unit
Kiel, Germany
Sponsor: Merck Healthcare KGaA
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.